• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对冠状动脉旁路移植术后早期和晚期结局的影响。

Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.

作者信息

Thourani V H, Weintraub W S, Stein B, Gebhart S S, Craver J M, Jones E L, Guyton R A

机构信息

Department of Surgery, Emory Center for Outcomes Research, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Ann Thorac Surg. 1999 Apr;67(4):1045-52. doi: 10.1016/s0003-4975(99)00143-5.

DOI:10.1016/s0003-4975(99)00143-5
PMID:10320249
Abstract

BACKGROUND

Diabetes mellitus is an established independent risk factor for significant morbidity and mortality after coronary artery bypass grafting.

METHODS

The impact of diabetes on short- and longterm follow-up after coronary artery bypass grafting was studied by comparing the outcomes between 9,920 patients without diabetes mellitus and 2,278 patients with diabetes from 1978 to 1993.

RESULTS

Compared with nondiabetic patients, the group with diabetes was older (62+/-10 years versus 60+/-10 years), comprised more women (31% versus 19%), had a greater incidence of hypertension (61% versus 44%) and previous myocardial infarction (51% versus 48%), had class III-IV angina more commonly (69% versus 63%), showed a higher incidence of congestive heart failure (11% versus 5%) or triple-vessel or left main disease (60% versus 50%), and had lower ejection fractions (0.54 versus 0.57) (all, p< or =0.05). Diabetic patients had a higher incidence of postoperative death (3.9% versus 1.6%) and stroke (2.9% versus 1.4%) (both, p< or =0.05), but not Q wave myocardial infarction (1.8% versus 2.9%). Diabetics had lower survival (5 years, 78% versus 88%; 10 years, 50% versus 71%; both, p< or =0.05) and lower freedom from percutaneous transluminal coronary angioplasty (5 years, 95% versus 96%; 10 years, 83% versus 86%; latter, p< or =0.05), but diabetics did not have lower freedom from either myocardial infarction (5-years, 92% versus 92%; 10-years, 80% versus 84%) or additional coronary artery bypass grafting (5-years, 98% versus 99%; 10-years, 90% versus 91%). Multivariate correlates of long-term mortality were diabetes, older age, reduced ejection fraction, hypertension, congestive heart failure, number of vessels diseased, and urgent or emergent operation.

CONCLUSIONS

Diabetics have a worse hospital and longterm outcome after coronary artery bypass grafting. The increased risk in such patients can only partially be explained by other demographic characteristics.

摘要

背景

糖尿病是冠状动脉搭桥术后发生严重发病和死亡的既定独立危险因素。

方法

通过比较1978年至1993年间9920例非糖尿病患者和2278例糖尿病患者的结局,研究糖尿病对冠状动脉搭桥术后短期和长期随访的影响。

结果

与非糖尿病患者相比,糖尿病组年龄更大(62±10岁对60±10岁),女性更多(31%对19%),高血压发病率更高(61%对44%),既往心肌梗死发生率更高(51%对48%),Ⅲ-Ⅳ级心绞痛更常见(69%对63%),充血性心力衰竭或三支血管或左主干病变发生率更高(60%对50%),射血分数更低(0.54对0.57)(所有比较,p≤0.05)。糖尿病患者术后死亡(3.9%对1.6%)和中风(2.9%对1.4%)的发生率更高(两者均p≤0.05),但Q波心肌梗死发生率无差异(1.8%对2.9%)。糖尿病患者生存率更低(5年时,78%对88%;10年时,50%对71%;两者均p≤0.05),免于经皮冠状动脉腔内血管成形术的比例更低(5年时,95%对96%;10年时,83%对86%;后者p≤0.05),但糖尿病患者免于心肌梗死(5年时,92%对92%;10年时,80%对84%)或再次冠状动脉搭桥术(5年时,98%对99%;10年时,90%对91%)的比例并无降低。长期死亡率的多变量相关因素包括糖尿病、年龄较大、射血分数降低、高血压、充血性心力衰竭、病变血管数量以及急诊或紧急手术。

结论

糖尿病患者冠状动脉搭桥术后的住院和长期结局较差。此类患者风险增加只能部分由其他人口统计学特征来解释。

相似文献

1
Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.糖尿病对冠状动脉旁路移植术后早期和晚期结局的影响。
Ann Thorac Surg. 1999 Apr;67(4):1045-52. doi: 10.1016/s0003-4975(99)00143-5.
2
Coronary artery bypass grafting in patients with advanced left ventricular dysfunction.晚期左心室功能不全患者的冠状动脉旁路移植术
Ann Thorac Surg. 1998 Nov;66(5):1632-9. doi: 10.1016/s0003-4975(98)00773-5.
3
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.阿根廷多支血管病变患者经皮腔内冠状动脉成形术与冠状动脉搭桥手术对比的随机试验(ERACI):住院结果及1年随访。ERACI研究组
J Am Coll Cardiol. 1993 Oct;22(4):1060-7. doi: 10.1016/0735-1097(93)90416-x.
4
The influence of gender on the outcome of coronary artery bypass surgery.性别对冠状动脉搭桥手术结果的影响。
Ann Thorac Surg. 2000 Sep;70(3):800-5; discussion 806. doi: 10.1016/s0003-4975(00)01563-0.
5
Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery.冠状动脉成形术与再次冠状动脉旁路移植术用于曾接受旁路手术的患者
J Am Coll Cardiol. 1996 Nov 1;28(5):1140-6. doi: 10.1016/S0735-1097(96)00286-0.
6
Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.影响微创直接冠状动脉旁路移植术后心肌梗死发生率、经皮冠状动脉腔内血管成形术、冠状动脉旁路移植术及心源死亡率的因素。
Interact Cardiovasc Thorac Surg. 2009 Jan;8(1):49-53. doi: 10.1510/icvts.2008.185280. Epub 2008 Sep 11.
7
Single versus bilateral internal mammary artery grafts: 10-year outcome analysis.单支与双侧乳内动脉移植:10年结果分析。
Ann Thorac Surg. 1997 Sep;64(3):599-605. doi: 10.1016/s0003-4975(97)00620-6.
8
Minimally invasive direct coronary artery bypass grafting: two-year clinical experience.
Ann Thorac Surg. 1997 Dec;64(6):1648-53; discussion 1654-5. doi: 10.1016/s0003-4975(97)01099-0.
9
Effect of gender on postoperative outcomes and hospital stays after coronary artery bypass grafting.性别对冠状动脉搭桥术后结局及住院时间的影响。
Ann Thorac Surg. 1999 Apr;67(4):1097-103. doi: 10.1016/s0003-4975(99)00055-7.
10
Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.糖尿病对经皮腔内冠状动脉成形术后早期和晚期预后的影响。
Circulation. 1995 Feb 15;91(4):979-89. doi: 10.1161/01.cir.91.4.979.

引用本文的文献

1
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.优化糖尿病患者心脏手术的预后:OCTOPuS试点可行性研究
Health Technol Assess. 2025 Aug;29(39):1-31. doi: 10.3310/POYW3311.
2
Nanopathways modulating postoperative cognitive dysfunction: extracellular vesicles.调节术后认知功能障碍的纳米途径:细胞外囊泡
Front Cell Dev Biol. 2025 Jun 30;13:1613378. doi: 10.3389/fcell.2025.1613378. eCollection 2025.
3
Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus - In Tertiary Care Center.
血脂异常和代谢功能在2型糖尿病合并冠心病中的作用——在三级医疗中心的研究
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S913-S915. doi: 10.4103/jpbs.jpbs_1975_24. Epub 2025 Feb 21.
4
Effect of glycaemic control on coronary artery bypass grafting outcomes - a United Kingdom centre experience.血糖控制对冠状动脉旁路移植术结局的影响——英国一家中心的经验
JRSM Cardiovasc Dis. 2025 Mar 18;14:20480040251325918. doi: 10.1177/20480040251325918. eCollection 2025 Jan-Dec.
5
Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension.心脏停搏和体外循环后的微血管功能障碍:糖尿病和高血压的影响。
Biomedicines. 2025 Feb 7;13(2):409. doi: 10.3390/biomedicines13020409.
6
Frequency and Predictors of Pneumonia After Isolated Coronary Artery Bypass Grafting (CABG): A Single-Center Study.单纯冠状动脉旁路移植术(CABG)后肺炎的发生率及预测因素:一项单中心研究
Diagnostics (Basel). 2025 Jan 16;15(2):195. doi: 10.3390/diagnostics15020195.
7
Glycemic control after aortic valve replacement: A retrospective study.主动脉瓣置换术后的血糖控制:一项回顾性研究。
Int J Cardiol Heart Vasc. 2025 Jan 2;56:101596. doi: 10.1016/j.ijcha.2024.101596. eCollection 2025 Feb.
8
Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities.糖尿病合并癌症患者的围手术期管理:挑战与机遇
Cancers (Basel). 2024 Aug 11;16(16):2821. doi: 10.3390/cancers16162821.
9
The predictive role of modified stress hyperglycemia rate in predicting early pneumonia after isolated coronary bypass surgery in patients with diabetes mellitus.改良应激性高血糖率在预测糖尿病患者单纯冠状动脉搭桥术后早期肺炎中的预测作用。
Biomol Biomed. 2025 Jan 14;25(2):505-510. doi: 10.17305/bb.2024.10330.
10
Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma.高血糖对肝细胞癌经动脉化疗栓塞术后并发症和死亡率的影响。
Diabetes Metab J. 2024 Mar;48(2):302-311. doi: 10.4093/dmj.2022.0255. Epub 2024 Jan 3.